IP Verse

Pharmaceutical Compositions For The Treatment Of Cystic Fibrosis Transmembrane Conductance Regulator Mediated Diseases - EP3131582

PATENT ANALYSIS

Patent Details

Grant Date
May 23, 2018
Company
VERTEX PHARMACEUTICALS INCORPORATED
Oppositions

GENERICS (U.K.) LIMITED

More patents of Vertex Pharmaceuticals Incorporated

EP2464337

EP2914248

EP3925607

Want to monitor this patent?

Feel free to send us a message here and we will get back to you